Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-059999)

Filing Details

Accession Number:: 0001209191-22-059999
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-12-06 16:21:04
Reporting Period:: 2022-12-01

Accepted Time:: 2022-12-06 16:21:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1652724	Lucira Health Inc.	LHDX	In Vitro & In Vivo Diagnostic Substances (2835)	272491037

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1956050	Clavano Richard Narido	1412 62Nd St Emeryville CA 94608	Interim Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-12-01	1,583	$0.36	107,293	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Unitsgranted on March 30, 2021 for 69,975 shares.